Sub Banner Image

Well-Timed Bearish Drug ETF Bet Pays Off on Vaccine Chief News

Markets

David Marino

·

May 6, 2025

·

Bloomberg

An unusually large bearish bet on a drug ETF gained almost $800,000 as drug stocks reeled following the appointment of Vinay Prasad as director of the Food and Drug Administration’s Center for Biologics and Research.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.